marketcaparena

EIKN

Eikon Therapeutics, Inc.

Company overview

Market capitalization
$428.45M
Employees
384
Latest publication
2026-09-29
About Eikon Therapeutics, Inc.

Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent WRN helicase inhibitor and anti-tumor agent for MSI-high tumors; and EIK1006, a clinical candidate and next-generation androgen receptor antagonist with activity against multiple clinically emergent variants of androgen receptor. The company was incorporated in 2019 and is based in Millbrae, California.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USD
Total Revenue0USD0USD0USD0USD
Cost Of Revenue5,113,000USD5,105,000USD——
Gross Profit-5,113,000USD-5,105,000USD——
Research Development70,047,000USD65,229,000USD56,587,000USD53,860,000USD
Selling General Administrative17,290,000USD17,939,000USD14,796,000USD13,917,000USD
Unclassified Operating Expenses-5,113,000USD-5,105,000USD——
Total Operating Expenses82,224,000USD78,063,000USD71,383,000USD67,777,000USD
Operating Income-87,337,000USD-83,168,000USD-71,383,000USD-67,777,000USD
Interest Income4,380,000USD3,474,000USD3,160,000USD2,855,000USD
Net Interest Income4,380,000USD3,522,000USD3,160,000USD2,848,000USD
Income Before Tax-82,958,000USD-79,655,000USD-68,243,000USD-64,924,000USD
Net Income-82,958,000USD-79,655,000USD-68,243,000USD-64,924,000USD
Net Income From Continuing Ops-82,958,000USD-79,655,000USD-68,243,000USD-64,924,000USD
Ebit-87,337,000USD-83,168,000USD——
Ebitda-82,224,000USD-78,063,000USD——
Depreciation And Amortization5,113,000USD5,105,000USD——
Reconciled Depreciation5,113,000USD5,105,000USD6,466,000USD6,215,000USD
Total Other Income Expense Net4,379,000USD3,513,000USD-20,000USD5,000USD
Interest Expense—48,000USD—7,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USD
Total Revenue0USD0USD0USD
Cost Of Revenue24,176,000USD——
Gross Profit-24,176,000USD——
Research Development250,318,000USD204,536,000USD207,261,000USD
Selling General Administrative88,627,000USD55,807,000USD58,476,000USD
Unclassified Operating Expenses-24,176,000USD——
Total Operating Expenses314,769,000USD260,343,000USD265,737,000USD
Operating Income-338,945,000USD-260,343,000USD-265,737,000USD
Interest Income15,566,000USD16,563,000USD23,737,000USD
Interest Expense837,000USD31,000USD39,000USD
Net Interest Income14,729,000USD16,532,000USD23,698,000USD
Income Before Tax-324,248,000USD-243,814,000USD-241,997,000USD
Net Income-324,248,000USD-243,814,000USD-241,997,000USD
Net Income From Continuing Ops-324,248,000USD-243,814,000USD-241,997,000USD
Ebit-338,945,000USD——
Ebitda-314,769,000USD——
Depreciation And Amortization24,176,000USD——
Reconciled Depreciation24,176,000USD25,392,000USD17,748,000USD
Total Other Income Expense Net14,697,000USD-3,000USD42,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ4 20242024-12-31 · USD
Total Assets779,570,000USD850,826,000USD594,734,000USD642,337,000USD491,240,000USD
Cash And Equivalents142,613,000USD————
Cash And Short Term Investments531,178,000USD512,582,000USD335,975,000USD375,854,000USD—
Short Term Investments388,565,000USD351,028,000USD231,074,000USD270,986,000USD90,932,000USD
Total Current Assets546,978,000USD529,501,000USD348,917,000USD390,496,000USD227,889,000USD
Other Current Assets15,400,000USD16,919,000USD12,942,000USD14,642,000USD7,378,000USD
Other Non Current Assets539,000USD————
Total Liabilities313,070,000USD————
Total Current Liabilities55,296,000USD45,064,000USD55,007,000USD44,394,000USD56,449,000USD
Other Non Current Liabilities15,000,000USD————
Total Stockholder Equity466,500,000USD550,671,000USD-879,034,000USD-804,354,000USD-571,930,000USD
Total Equity Including Noncontrolling Interest466,500,000USD————
Property Plant Equipment Net224,208,000USD229,133,000USD233,863,000USD241,150,000USD259,132,000USD
Accounts Payable6,564,000USD6,005,000USD681,000USD4,282,000USD17,578,000USD
Short Term Debt9,445,000USD9,740,000USD10,028,000USD9,905,000USD—
Common Stock5,000USD5,000USD———
Retained Earnings-1,091,876,000USD-1,003,467,000USD-920,509,000USD-840,854,000USD-604,941,000USD
Total Liab—300,155,000USD1,473,768,000USD1,446,691,000USD1,063,170,000USD
Other Current Liab—29,319,000USD44,298,000USD30,207,000USD301,000USD
Capital Stock—5,000USD0USD0USD0USD
Cash—161,554,000USD104,901,000USD104,868,000USD129,179,000USD
Net Debt—93,277,000USD152,418,000USD135,862,000USD—
Short Long Term Debt Total—254,831,000USD257,319,000USD240,730,000USD—
Long Term Investments—83,828,000USD———
Property Plant Equipment Gross—277,227,000USD276,777,000USD279,178,000USD293,034,000USD
Common Stock Shares Outstanding—54,138,555shares54,138,555shares53,984,337shares53,984,337shares
Non Current Assets Total—321,325,000USD245,817,000USD251,841,000USD263,351,000USD
Non Current Liabilities Total—255,090,999USD1,418,761,000USD1,402,297,000USD1,006,721,000USD
Non Current Liabilities Other—10,000,000USD10,000,000USD10,002,000USD5,348,000USD
Non Currrent Assets Other—556,000USD11,954,000USD10,691,000USD4,219,000USD
Net Working Capital—484,437,000USD293,910,000USD346,102,000USD171,440,000USD
Unclassified Non Current Assets—7,808,000USD———
Unclassified Non Current Liabilities—245,090,999USD1,408,761,000USD1,392,295,000USD1,001,373,000USD
Unclassified Equity—1,554,128,000USD41,475,000USD36,500,000USD33,011,000USD
Unclassified Current Liabilities————38,570,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USD
Total Assets594,734,000USD491,240,000USD525,705,000USD
Other Current Assets12,942,000USD7,378,000USD6,012,000USD
Total Liab1,473,768,000USD1,063,170,000USD867,078,000USD
Total Stockholder Equity-879,034,000USD-571,930,000USD-341,373,000USD
Other Current Liab44,298,000USD301,000USD591,000USD
Capital Stock0USD0USD0USD
Retained Earnings-920,509,000USD-604,941,000USD-361,127,000USD
Cash104,901,000USD129,179,000USD112,784,000USD
Cash And Short Term Investments335,975,000USD——
Total Current Assets348,917,000USD227,889,000USD436,425,000USD
Total Current Liabilities55,007,000USD56,449,000USD31,440,000USD
Net Debt152,418,000USD——
Short Term Debt10,028,000USD——
Short Long Term Debt Total257,319,000USD——
Short Term Investments231,074,000USD90,932,000USD317,629,000USD
Accounts Payable681,000USD17,578,000USD2,187,000USD
Property Plant Equipment Net233,863,000USD259,132,000USD86,880,000USD
Property Plant Equipment Gross276,777,000USD293,034,000USD105,775,000USD
Common Stock Shares Outstanding54,138,555shares53,984,337shares53,984,337shares
Non Current Assets Total245,817,000USD263,351,000USD89,279,000USD
Non Current Liabilities Total1,418,761,000USD1,006,721,000USD835,638,000USD
Non Current Liabilities Other10,000,000USD5,348,000USD730,000USD
Non Currrent Assets Other11,954,000USD4,219,000USD2,399,000USD
Net Working Capital293,910,000USD171,440,000USD404,985,000USD
Unclassified Non Current Liabilities1,408,761,000USD1,001,373,000USD834,908,000USD
Unclassified Equity41,475,000USD33,011,000USD19,754,000USD
Unclassified Current Liabilities—38,570,000USD28,662,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow YTD

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USD
Depreciation10,343,000USD
Stock Based Compensation6,996,000USD
Change To Liabilities10,821,000USD
Change In Working Capital5,821,000USD
Operating Cash Flow-154,759,000USD
Capital Expenditures-513,000USD
Net Investments-156,275,000USD
Investing Cash Flow-156,788,000USD
Financing Cash Flow349,333,000USD
Change In Cash37,786,000USD
End Cash Flow150,858,000USD
SourceDisclosureDeterministicFinal

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USD
Net Income-82,958,000USD-79,655,000USD-68,243,000USD-64,924,000USD
Depreciation5,113,000USD5,105,000USD6,466,000USD6,215,000USD
Stock Based Compensation2,777,000USD3,861,000USD2,970,000USD3,179,000USD
Other Non Cash Items1,950,000USD-654,000USD-1,234,000USD-1,435,000USD
Change In Working Capital-13,906,000USD29,619,000USD5,520,000USD33,225,000USD
Total Cash From Operating Activities-89,801,000USD-41,724,000USD-54,521,000USD-23,740,000USD
Capital Expenditures-262,000USD-66,000USD-22,358,000USD-39,518,000USD
Free Cash Flow-90,063,000USD-41,790,000USD-76,879,000USD-63,258,000USD
Investments-202,955,000USD40,776,000USD-191,496,000USD47,671,000USD
Total Cashflows From Investing Activities-203,217,000USD40,710,000USD——
Total Cash From Financing Activities349,308,000USD1,089,000USD350,234,000USD95,000USD
Issuance Of Capital Stock349,308,000USD1,089,000USD350,234,000USD95,000USD
Change In Cash56,253,000USD75,000USD81,859,000USD-15,492,000USD
Begin Period Cash Flow105,301,000USD112,997,000USD130,878,000USD146,370,000USD
End Period Cash Flow161,554,000USD113,072,000USD212,737,000USD130,878,000USD
Unclassified Operating Cash Flow-2,777,000USD———
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USD
Net Income-324,248,000USD-243,814,000USD-241,997,000USD
Depreciation24,176,000USD25,392,000USD17,748,000USD
Stock Based Compensation18,036,000USD12,429,000USD9,538,000USD
Other Non Cash Items15,685,000USD-9,456,000USD13,887,000USD
Change In Working Capital77,835,000USD80,650,000USD9,976,000USD
Total Cash From Operating Activities-188,516,000USD-134,799,000USD-190,848,000USD
Capital Expenditures-46,741,000USD-84,803,000USD-28,513,000USD
Free Cash Flow-235,257,000USD-219,602,000USD-219,361,000USD
Investments-134,602,000USD236,153,000USD165,463,000USD
Total Cashflows From Investing Activities-181,343,000USD——
Total Cash From Financing Activities352,053,000USD244,000USD105,812,000USD
Issuance Of Capital Stock352,053,000USD244,000USD105,812,000USD
Change In Cash-17,806,000USD16,795,000USD51,914,000USD
Begin Period Cash Flow130,878,000USD114,083,000USD62,169,000USD
End Period Cash Flow113,072,000USD130,878,000USD114,083,000USD
Other Cashflows From Financing Activities350,153,000USD——
Unclassified Financing Cash Flow-350,153,000USD——
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

No revenue breakdown is currently published for this company.

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.